Adverse prognostic impact of the loss of STAG2 protein expression in patients with newly diagnosed localised Ewing sarcoma: A report from the Children's Oncology Group.
David S ShulmanSonja ChenDavid HallAnwesha NagAaron R ThornerStephen L LessnickKimberly StegmaierKatherine A JanewaySteven G DuBoisMark D KrailoDonald A BarkauskasAlanna J ChurchBrian D CromptonPublished in: British journal of cancer (2022)
STAG2 loss of expression is identified in a population of patients without identifiable STAG2 mutations and carries a poor prognosis.